No title
Ovarian cancer is one of the deadliest cancer forms in women and is a disease in need of improved biomarkers for detection and drug targets alike. Such molecules can be discovered by studying the proteome of the cells. Phosphoproteomic studies have become increasingly more popular as it has a high potential for mapping cell signaling and to find new signaling molecules for drug targeting. Currentl
